Acute effects of statin on reduction of angiopoietin-like 2 and glyceraldehyde-derived advanced glycation end-products levels in patients with acute myocardial infarction: a message from SAMIT (Statin for Acute Myocardial Infarction Trial)

Mitsuhiro Shimomura(Saga University), Koichi Node(Saga University), Masayoshi Takeuchi(Kanazawa Medical University), Yusuke Yamamoto(Saiseikai Fukuoka General Hospital), Aiko Komatsu(Saga University), Sho‐ichi Yamagishi(Kurume University), Tomohiro Kawasaki(Koga Hospital), Teruo Inoue(Dokkyo Medical University), Daigo Mine(Saga University), Jun‐ichi Oyama(Saga University), Masashi Sakuma(Saga University), Masahiro Natsuaki(Saga University), Yohei Inoue, Yoshisato Shibata, Kazuhisa Kodama(Saga University), Hiroshi Komoda(Saga University), Yutaka Hikichi(Saga University), Shigeru Toyoda(Dokkyo Medical University)
Heart and Vessels
December 23, 2015
10.1007/s00380-015-0773-y
Cited by 37

Related Papers

Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI
|JAMA|2019|830
JCS 2020 Guideline Focused Update on Antithrombotic Therapy in Patients With Coronary Artery Disease
|Circulation Journal|2020|345
1-Year Impact on Medical Practice and Clinical Outcomes of FFRCT
|JACC. Cardiovascular imaging|2019|309
Real-world clinical utility and impact on clinical decision-making of coronary computed tomography angiography-derived fractional flow reserve: lessons from the ADVANCE Registry
|European Heart Journal|2018|305
Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome
|JAMA Cardiology|2022|296